TJ-CP3B

N/A

Report date: 2026/03/19 17:03:42

Base Information

Drug NameTJ-CP3B
Drug Alias NameAnti-CD3/anti-4-1BB/anti-CDCP1 tri-specific T cell engager(I-Mab Biopharma Co Ltd)TJ-CP3BTJCP3B
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Trispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionAnti-CD3Anti-Tumor necrosis factor receptor superfamily member 9Anti-CUB domain-containing protein 1
TargetsT cell surface glycoprotein CD3Tumor necrosis factor receptor superfamily member 9CUB domain-containing protein 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesI-Mab Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesI-Mab Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A